BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 21531502)

  • 1. The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: a systematic review.
    Lammers RJ; Witjes JA; Inman BA; Leibovitch I; Laufer M; Nativ O; Colombo R
    Eur Urol; 2011 Jul; 60(1):81-93. PubMed ID: 21531502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of the combined regimen with local chemotherapy and Mw-induced hyperthermia for non-muscle invasive bladder cancer management. A systematic review].
    Colombo R; Moschini M
    Urologia; 2013; 80(2):112-9. PubMed ID: 23852928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical radiofrequency-induced hyperthermia combined with chemotherapy for non-muscle-invasive bladder cancer.
    van Valenberg H; Colombo R; Witjes F
    Int J Hyperthermia; 2016 Jun; 32(4):351-62. PubMed ID: 26905963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of hyperthermia as a treatment for non-muscle invasive bladder cancer.
    Bahouth Z; Halachmi S; Moskovitz B; Nativ O
    Expert Rev Anticancer Ther; 2016; 16(2):189-98. PubMed ID: 26618756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency-induced thermo-chemotherapy effect (RITE) for non muscle invasive bladder cancer treatment: current role and perspectives.
    Colombo R; van Valenberg H; Moschini M; Witjes JA
    Urologia; 2016 Oct; 83(Suppl 2):7-17. PubMed ID: 27768213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical bacillus Calmette-Guerin versus mitomycin C for Ta and T1 bladder cancer.
    Shelley MD; Court JB; Kynaston H; Wilt TJ; Coles B; Mason M
    Cochrane Database Syst Rev; 2003; (3):CD003231. PubMed ID: 12917955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer.
    Arends TJ; Nativ O; Maffezzini M; de Cobelli O; Canepa G; Verweij F; Moskovitz B; van der Heijden AG; Witjes JA
    Eur Urol; 2016 Jun; 69(6):1046-52. PubMed ID: 26803476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemohyperthermia using MMC in non-muscle-invasive bladder cancer: Current status and future perspectives.].
    Coenen JJMJH; van Valenberg FJP; Arends TJH; Witjes JA
    Arch Esp Urol; 2018 May; 71(4):400-408. PubMed ID: 29745929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer.
    Malmström PU; Sylvester RJ; Crawford DE; Friedrich M; Krege S; Rintala E; Solsona E; Di Stasi SM; Witjes JA
    Eur Urol; 2009 Aug; 56(2):247-56. PubMed ID: 19409692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectivity of intravescical thermo-chemotherapy prophylaxis for patients with high recurrence and progression risk for non-muscle invasive bladder cancer.
    Gözen AS; Umari P; Scheitlin W; Su FE; Akin Y; Rassweiler J
    Arch Ital Urol Androl; 2017 Jun; 89(2):102-105. PubMed ID: 28679178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the bladder.
    Halachmi S; Moskovitz B; Maffezzini M; Conti G; Verweij F; Kedar D; Sandri SD; Nativ O; Colombo R
    Urol Oncol; 2011; 29(3):259-64. PubMed ID: 19395285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of an Immediate Intravesical Instillation of Mitomycin C in Patients with Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Randomised Study in 2243 patients.
    Bosschieter J; Nieuwenhuijzen JA; van Ginkel T; Vis AN; Witte B; Newling D; Beckers GMA; van Moorselaar RJA
    Eur Urol; 2018 Feb; 73(2):226-232. PubMed ID: 28705539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemohyperthermia in non-muscle-invasive bladder cancer: An overview of the literature and recommendations.
    Liem EI; Crezee H; de la Rosette JJ; de Reijke TM
    Int J Hyperthermia; 2016 Jun; 32(4):363-73. PubMed ID: 27056069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravesical instillations in non-muscle-invasive bladder cancer (NMIBC). Prospects for thermochemotherapy].
    Irani J
    Prog Urol; 2016 Nov; 26(14):860-864. PubMed ID: 27712914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of tolerance and security of chemo hyperthermia with Mitomycin C for the treatment of non-muscle invasive bladder cancer.
    León-Mata J; Domínguez JL; Redorta JP; Sousa González D; Alvarez Casal M; Sousa Escandón A; Piñeiro Vázquez E
    Arch Esp Urol; 2018 May; 71(4):426-437. PubMed ID: 29745932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer.
    Racioppi M; Di Gianfrancesco L; Ragonese M; Palermo G; Sacco E; Bassi P
    Eur Urol Oncol; 2019 Sep; 2(5):576-583. PubMed ID: 31411974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Review on the Utilization of Maintenance Intravesical Chemotherapy in the Management of Non-muscle-invasive Bladder Cancer.
    Tabayoyong WB; Kamat AM; O'Donnell MA; McKiernan JM; Ray-Zack MD; Palou J; Brausi M; Black PC; Williams SB
    Eur Urol Focus; 2018 Jul; 4(4):512-521. PubMed ID: 30190111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravesical electro-osmotic administration of mitomycin C.
    Di Stasi SM; Verri C; Celestino F; De Carlo F; Pagliarulo V
    Urologia; 2016 Oct; 83(Suppl 2):18-23. PubMed ID: 27716887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bladder intracavitary hyperthermic perfusion chemotherapy for the prevention of recurrence of non-muscle invasive bladder cancer after transurethral resection.
    Ba M; Cui S; Wang B; Long H; Yan Z; Wang S; Wu Y; Gong Y
    Oncol Rep; 2017 May; 37(5):2761-2770. PubMed ID: 28405683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary cytokines in patients treated with intravesical mitomycin-C with and without hyperthermia.
    Arends TJ; Falke J; Lammers RJ; Somford DM; Hendriks JC; de Weijert MC; Arentsen HC; van der Heijden AG; Oosterwijk E; Alfred Witjes J
    World J Urol; 2015 Oct; 33(10):1411-7. PubMed ID: 25491674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.